medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2016, Number 620

<< Back Next >>

Rev Med Cos Cen 2016; 73 (620)

Hipotiroidismo en el embarazo

Núñez DN

Language: Spanish
References: 16
Page: 637-640
PDF size: 174.73 Kb.


ABSTRACT

Hypotthyroidism is the most common thyroid disease, when appears with elevated TSH and decreased free T4 is called over hypothyroidism, and when is only manifested with elevated THS and with normal free T4 values is called subclinical hypothyroidism. The most common cause is autoimmune etiology. The diagnosis during pregnancy is made with THS and the diagnosis values depend on the trimester. Screening pregnant women is only recommended when the patient has any risk factors. The treatment is levothyroxine and is indicated in all patients diagnosed with clinical hypothyroidism before or during pregnancy and in patients with subclinical hypothyroidism who develop symptoms.


REFERENCES

  1. Aghahosseini M, Asgharifard H, Aleyasin A, Teharani A. Effects of thyroid stimulating hormone (TSH) level on clinical pregnancy rate via in vitro fertilization (IVF) procedure. Med J Islam Repub Iran. 2014 Jun 15; 28: 1-4.

  2. Brabant G, Peeters R, Chan S, Bernal J, Bouchard P, Salvatore D, Boelaert K, Laurberg P. Management of subclinical hypothyroidism in pregnancy: are we too simplistic?. Eur J Endocrinol. 2015 Jul; 173 (1): P1-P11.

  3. Chen L, Du W, Dai J, Zhang Q, Si G, Yang H, Ye E, Chen Q, Yu L, Zhang C, Lu X. Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PLoS One, 2014 Oct 29; 9 (10): e109364.

  4. Dave A, Maru L, Tripathi M. Importance of universal screening for thyroid disorders in first trimester of pregnancy. Indian J Endocrinol Metab. 2014 Sep; 18 (5): 725-738.

  5. Han C, Li C, Mao J, Wang W, Xie X, Zhou W, Li C, Xu B, Bi L, Meng T, Du J, Zhang S, Gao Z, Zhang X, Yang L, Fan C, Teng W, Shan Z. High body mass index is an indicator of maternal hypothyroidism, hypothyroxinemia, and thyroidperoxidase antibody positivity during early pregnancy. Biomed Res Int. 2015 Aug 27; 1-7.

  6. Joshi D, Dewan R, Bharti R, Thariani K, Sablock A, Sahrma M, Biswas K, Batra A. Feto-maternal outcome using new screening criteria of serum TSH for diagnosis hypothyroidism in pregnancy. J Clin Diagn Res. 2015 Apr; 9 (4): QC01-QC03.

  7. Krassas G, Karras S, Pontikides N. Thyroid diseases during pregnancy: a number of important issues. Hormones. 2015 Jan-Mar; 14 (1): 59-69.

  8. Lazarus J, Brown R, Daumerie C, Hubalewska A, Negro R, Vaidya B. 2014 European Thyroid Association guidelines for management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014 Jun; 3 (2): 76-94.

  9. Medeiros MF, Cequeira TL, Silva Junior JC, Amaral MT, Vaidya B, Poppe KG, Carvalho GA, Gutierrez S, Alcaraz G, Abalovich M, Ramos HE.. An international surve of screening and management of hypothyroidism during pregnancy in Latin America. Arq Bras Endocrinol Metabol. 2014 Dec; 58 (9): 906- 911.

  10. Saki F, Hossein M, Zahra S, Forouhari S, Ranjbar G, Bakhshayeshkaram M. Thyroid function in pregnancy and its influences on maternal and fetal outcomes. Int J Endocrinol Metab. 2014 Oct 1; 12 (4): e 19378.

  11. Kim HS, Kim BJ, Oh S, Lee da Y, Hwang KR, Jeon HW, Lee SM. Gestational age-specific cut-off values are needed for diagnosis of subclinical hypotiroidism in early pregnancy.

  12. Raza SA, Mahmood N. Subclinical hypothyroidism: controversies to consensus. Indian J Endocrinol Metab. 2013 Dec; 17 (3): S636-S642.

  13. Sweeney LB, Stewart C, Gaitonde DY. Thyroiditis: an integrated approach. Am Fam Physician. 2014 Sep 15; 90 (6): 389-396.

  14. Villagelin D, Comarella AP, Tiago DB, Ward LS. Management of gestational hypothyroidism: results of a Brazilian survey. Arch Endocrinol Metab. 2015 Aug 28; 1-4.

  15. Yang H, Shao M, Chen L, Chen Q, Yu L, Cai L, Lin Zhenzhen, Zhang C, Lu X. Screening strategies for thyroid disorders in the first and second trimester of pregnancy in China. PLoS One. 2014 Jun 12; 9 (6): e99611.

  16. Zornitzki T, Froimovici M, Amster R, Lurie S. Point prevalence of abnormal thyroid-Stimulating hormone during the first trimester of pregnancy in Israel. Isr Med Assoc J. 2014 Sep; 16 (9): 564-567.




2020     |     www.medigraphic.com